ELTX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 19:51):
Our systems believe the stock currently is undervalued by 0.02% compare to its pairs and should correct upwards.

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases...

Stats
Dagens volum	7 909
Gjennomsnittsvolum	46 933
Markedsverdi	66.24M
EPS	$-1.150 ( Q1 \| 2024-03-31 )
Neste inntjeningsdato	( $-0.960 ) 2024-08-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.690 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0780 (1.21%)

AADI -8.24%

ABCL 1.28%

ABCM 0.04%

ABEO -3.32%

ABIO -1.68%

ABOS 3.73%

ABSI 3.74%

ABUS -0.82%

ABVX -3.00%

ACAD -0.32%

ACER -17.95%

ACET -9.15%

ACGN 1.29%

ACHL -2.48%

ACHV 3.66%

ACIU -1.50%

ACLX -0.44%

ACRV -5.28%

ACST -1.63%

ACXP 3.92%

ADAG 6.07%

ADAP -3.42%

ADGI 0.87%

ADIL -1.75%

ADMA -1.95%

ADPT 0.74%

ADTX -2.78%

ADVM 0.87%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -2.97%

AGEN -3.90%

AGIO -2.19%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 4.38%

AKRO -2.51%

AKTX 0.35%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC -0.11%

ALGS -1.52%

ALKS 1.61%

ALLK -11.44%

ALLO -4.17%

ALLR -0.88%

ALNA 3.16%

ALNY 2.22%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -14.30%

ALVR -0.76%

ALXN 0.00%

ALXO -14.18%

ALZN 4.02%

AMRN -2.48%

AMTI -3.13%

ANAB 1.01%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 1.96%

ANPC -3.15%

APGE 0.71%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 0.89%

APLT -1.35%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 0.62%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -6.47%

ARDS -12.13%

ARDX 0.58%

ARGX -0.59%

ARNA 0.00%

ARPO -0.90%

ARQT -2.97%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.72%

ARWR -1.86%

ASLN -3.44%

ASMB -4.22%

ASND -2.13%

ATAI -4.83%

ATHA 6.89%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 4.83%

ATRA -3.60%

ATXI -2.78%

ATXS -1.11%

AUPH -1.16%

AURA 4.11%

AUTL -3.17%

AVBP -5.03%

AVEO 0.00%

AVIR -2.33%

AVRO -1.41%

AVTE -1.03%

AVTX -3.74%

AVXL -5.43%

AXLA 0.00%

AXSM -1.53%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.65%

BCAB -5.88%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 1.81%

BCTX 12.37%

BCTXW 13.02%

BCYC 0.70%

BDRX -4.01%

BDTX -0.64%

BEAM 2.19%

BFRA -2.91%

BGNE -2.25%

BIOR -4.69%

BIVI 2.79%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.18%

BLTE -1.13%

BLU 0.03%

BLUE -2.83%

BMEA -14.20%

BMRN 0.53%

BNOX 6.15%

BNTC -3.06%

BNTX -1.71%

BOLD -9.93%

BOLT -0.05%

BPMC -1.68%

BPTH -1.43%

BPTS -13.47%

BRNS -0.37%

BRTX -4.29%

BTAI 11.86%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.35%

CABA 1.66%

CADL 0.53%

CALA 0.00%

CALC -9.65%

CALT -1.59%

CAPR -0.86%

CARA -3.23%

CARM 6.96%

CASI 3.86%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.76%

CCXI 0.00%

CDAK 0.00%

CDIO -2.99%

CDIOW 24.00%

CDMO -1.55%

CDMOP 0.04%

CDT -1.68%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.58%

CDXS 8.28%

CELC -3.49%

CELU 1.33%

CELUW 11.80%

CERC -1.68%

CERE -1.61%

CERO -6.66%

CEROW -10.18%

CFRX -27.95%

CGEM -0.55%

CGEN -3.31%

CGON -1.62%

CGTX -3.98%

CHMA -6.00%

CHRS 4.13%

CINC 0.00%

CING 2.22%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -0.94%

CLGN 0.00%

CLLS -3.11%

CLNN -2.72%

CLNNW 0.00%

CLRB 7.04%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 4.00%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.38%

CNCE 0.00%

CNSP -35.21%

CNST 0.00%

CNTA 0.67%

CNTB -0.75%

CNTX -7.31%

COCP -2.00%

COEPW 32.45%

COGT -2.40%

CORT 2.63%

COYA -0.33%

CPRX -1.91%

CRBP -0.83%

CRBU -7.10%

CRDF 0.44%

CRGX -0.34%

CRIS -1.59%

CRNX -6.13%

CRSP 0.05%

CRTX 2.63%

CRVO -3.95%

CRVS 0.28%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -3.31%

CTNM 1.98%

CTXR -1.40%

CUE -3.11%

CVAC -7.20%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.82%

CYTO 0.00%

DARE 2.94%

DAWN -0.82%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 27.75%

DNLI -2.23%

DNTH -6.46%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL 0.63%

DYAI 9.68%

EARS -1.77%

EDIT -2.92%

EDSA 4.09%

EFTR 2.50%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 8.40%

ELEV -2.07%

ELOX 10.77%

ELTX -5.15%

ELVN -1.53%

ELYM 5.86%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA -0.73%

ENTO -4.97%

ENTX -1.34%

ENVB 4.81%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS 0.96%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -4.51%

ETON 2.90%

ETTX 0.00%

EVAX -0.71%

EVGN 5.02%

EVLO 0.00%

EWTX -0.89%

EXAI -0.94%

EXEL 0.52%

EYEG -0.69%

EYEN 0.00%

EYPT 0.97%

FATE -11.96%

FBIO 0.59%

FBIOP 0.87%

FBLG -5.18%

FBRX -0.02%

FDMT -5.42%

FENC -2.52%

FGEN -9.83%

FHTX 7.34%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.57%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.49%

FULC 1.00%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -3.08%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -2.43%

GHRS -3.72%

GLMD -4.09%

GLPG -1.68%

GLSI 5.01%

GLTO -3.31%

GLUE -3.69%

GLYC -11.89%

GMAB -0.47%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -4.65%

GNPX -3.43%

GNTA 3.94%

GOSS -9.45%

GOVX -1.36%

GOVXW 10.89%

GPCR -7.01%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.44%

GRTX -1.66%

GTHX 1.36%

GUTS 0.35%

GXGXW 41.67%

GYRE -4.99%

HALO -1.65%

HARP 0.09%

HCWB -6.13%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX -1.30%

HOOK 1.97%

HOTH -1.65%

HOWL 0.85%

HRMY 3.45%

HRTX 8.20%

HSTO 0.00%

HUMA 1.20%

HUMAW -6.26%

IBRX -6.88%

ICCC -3.10%

ICPT 0.21%

ICU 16.82%

ICUCW 9.30%

ICVX -0.91%

IDRA -23.04%

IDYA -3.23%

IFRX -2.78%

IGMS -1.61%

IKNA -1.19%

IKT -9.93%

IMAB 0.00%

IMCR -3.36%

IMGN 0.02%

IMGO 0.00%

IMMP 5.13%

IMMX -6.90%

IMNM 3.64%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.33%

IMTXW 6.00%

IMUX 2.31%

IMV 0.00%

IMVT -3.41%

INAB -0.72%

INBX -2.79%

INCY -2.25%

INDP 7.34%

INFI -52.38%

INKT 1.69%

INM 3.32%

INMB 4.03%

INO 2.99%

INSM -1.08%

INTS -1.96%

INVA 0.40%

INZY 1.72%

IOBT -10.24%

IONS 1.19%

IOVA -2.72%

IPA 3.00%

IPHA 5.08%

IPSC -2.73%

IRON -2.67%

ISEE 0.38%

ITOS 1.98%

ITRM 2.33%

IVA 6.96%

IVVD -0.41%

JAGX 1.05%

JANX -4.87%

JAZZ -1.10%

JNCE 0.00%

JSPR -2.07%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.45%

KALV -3.20%

KDNY 0.22%

KMPH -0.34%

KNSA -2.03%

KNTE -0.38%

KOD -8.10%

KPRX -4.08%

KPTI -8.46%

KRBP -10.00%

KRON 1.58%

KROS -0.53%

KRRO -2.42%

KRTX 0.03%

KRYS 0.19%

KTRA 14.58%

KTTA -0.65%

KTTAW 0.92%

KURA 0.68%

KYMR -3.43%

KYTX -4.13%

KZIA 2.36%

KZR -1.48%

LABP 0.57%

LBPH -0.32%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.71%

LENZ -3.17%

LEXX -1.54%

LEXXW -14.63%

LGND -1.18%

LGNDV 0.00%

LGVN -10.16%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -3.68%

LPTX -2.75%

LQDA -0.16%

LRMR 0.07%

LSTA -1.68%

LTRN 5.74%

LUMO 1.79%

LVTX -4.12%

LXEO -8.68%

LXRX -2.35%

LYEL -35.05%

LYRA 4.03%

MACK 0.10%

MBIO -11.22%

MBRX -1.43%

MCRB 2.94%

MDGL -2.24%

MDNA -13.16%

MDWD 3.46%

MDXG -1.69%

MEIP 0.00%

MESO -1.71%

MGNX -5.24%

MGTA -7.74%

MGTX -0.71%

MGX 2.14%

MIRM 0.48%

MIRO 0.59%

MIST 3.08%

MITO 0.00%

MLEC -5.95%

MLECW 2.31%

MLND -5.36%

MLTX -0.03%

MLYS -6.49%

MNKD -0.95%

MNMD 2.97%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.42%

MORF -3.20%

MREO 0.14%

MRKR -0.43%

MRNA -9.35%

MRNS -6.59%

MRSN -2.86%

MRTX -0.17%

MRUS -0.27%

MRVI -0.07%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.02%

MYMD 1.08%

NAMS 0.00%

NAMSW -0.42%

NAUT 0.89%

NBRV 0.71%

NBSE -1.56%

NBTX 8.40%

NCNA 0.37%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.31%

NKGN 10.91%

NKGNW -18.03%

NKTR 3.74%

NKTX -3.74%

NLSP 3.53%

NLSPW 26.67%

NMRA -1.94%

NMTR -42.97%

NOVN -24.84%

NRBO 14.44%

NRIX -0.91%

NRSN -2.74%

NRSNW 0.00%

NRXP -7.43%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.62%

NTEC -12.45%

NTHI 0.00%

NTLA -5.54%

NTRBW -31.07%

NUVL -1.41%

NVAX -7.07%

NVCT -7.46%

NVIV -34.28%

NXTC -5.29%

NYMX -0.05%

OABI 2.77%

OABIW -10.06%

OBIO 1.90%

OBSV 0.00%

OCEA -2.82%

OCGN 8.09%

OCS -1.00%

OCUL 0.76%

OCUP 1.31%

ODT -4.27%

OKYO 1.72%

OLMA -5.37%

OMER -2.57%

OMGA -1.24%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 1.33%

OPNT 0.00%

OPT -4.00%

ORGS -0.69%

ORIC -3.56%

ORMP 18.08%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.53%

OVID 0.30%

OYST 0.00%

PALI -0.22%

PASG 0.00%

PBLA -7.50%

PBM -4.69%

PBYI 2.70%

PCSA -1.93%

PCVX -0.14%

PDSB -6.94%

PEPG 1.37%

PGEN -7.19%

PHAR 2.19%

PHAS 0.00%

PHAT -0.87%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.38%

PLUR 7.39%

PMN -5.55%

PMVP -3.27%

PNT 0.16%

PPBT -6.87%

PRAX 6.98%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK -0.67%

PRQR 1.21%

PRTA -2.99%

PRTC 0.62%

PRTG 0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.97%

PSTX -3.30%

PTCT -0.74%

PTE -0.82%

PTGX -1.14%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 3.27%

QLGN -2.78%

QNCX 5.70%

QNRX -0.08%

QSI -31.62%

QSIAW -20.47%

QTTB 1.83%

QURE -1.12%

RAIN -1.63%

RANI 4.81%

RAPT -2.27%

RARE 2.23%

RCKT -10.02%

REGN -0.39%

RENB -3.11%

REPL -2.38%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -6.07%

RGNX -6.74%

RIGL -6.24%

RLAY -5.04%

RLMD 0.00%

RLYB -4.36%

RNA 1.85%

RNAC -4.73%

RNAZ -0.66%

RNXT 1.79%

ROIV -1.89%

ROIVW 4.56%

RPHM -1.86%

RPRX -0.71%

RPTX -0.88%

RUBY 2.70%

RVLP -32.05%

RVMD -0.88%

RVMDW -29.90%

RVNC -0.21%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.40%

RYTM -6.40%

RYZB 0.02%

RZLT 1.67%

SABS -1.37%

SABSW -11.81%

SAGE 0.05%

SANA -2.95%

SAVA -2.28%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 9.85%

SCPS 0.00%

SEEL -4.87%

SEER 0.30%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.43%

SGMT -5.33%

SGTX -2.56%

SIOX 22.63%

SLDB -2.76%

SLGL 5.23%

SLN -7.52%

SLNO 0.49%

SLRX -0.81%

SLS -2.56%

SMMT -3.25%

SNDX 2.97%

SNGX 2.08%

SNPX 0.23%

SONN -2.15%

SPPI -0.49%

SPRB -1.36%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.17%

SRRA 0.00%

SRRK -1.98%

SRZN -2.45%

STAB 0.00%

STOK -7.24%

STRO -2.67%

STSA 0.00%

STTK 6.47%

SURF -0.93%

SVRA -1.99%

SWTX -0.47%

SYBX 1.29%

SYRS -2.24%

TALS -0.73%

TARA -7.38%

TARS -2.49%

TBPH 0.71%

TCBP 9.58%

TCDA 0.00%

TCON 0.68%

TCRR 0.00%

TCRT -1.75%

TCRX 3.56%

TECH -0.86%

TENX -0.32%

TERN -8.15%

TFFP -7.61%

TGTX -6.93%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -6.26%

TNGX -3.46%

TNXP -6.40%

TNYA -4.38%

TPST 5.78%

TRDA -4.77%

TRVI 2.68%

TRVN 0.68%

TSHA -19.03%

TSVT -4.25%

TTNP -6.05%

TVTX 3.20%

TYRA -6.83%

UBX -2.13%

UNCY -4.84%

URGN 2.12%

UTHR -0.11%

VACC 11.36%

VALN -6.70%

VAXX 106.25%

VBIV 0.91%

VBLT -8.77%

VCEL 0.98%

VCNX 8.60%

VCYT -1.01%

VERA -5.26%

VERU 2.59%

VERV -2.87%

VIGL -1.08%

VINC 2.93%

VIR -1.19%

VIRI -5.66%

VIRX 3.98%

VKTX -1.69%

VLON -13.04%

VNDA -4.07%

VOR -6.05%

VRCA 0.50%

VRDN -4.23%

VRNA -1.86%

VRPX 1.02%

VRTX 0.08%

VSTM 4.40%

VTGN -1.20%

VTVT 0.39%

VTYX -3.14%

VXRT -1.86%

VYGR -0.83%

VYNE -6.29%

VYNT 7.78%

WINT -2.72%

WVE -8.81%

XBIO 1.03%

XBIT 6.72%

XCUR 3.13%

XENE -1.77%

XERS 4.52%

XFOR 4.69%

XLO 4.42%

XLRN 0.00%

XNCR 0.26%

XOMA -8.79%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.55%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.73%

ZNTL -2.02%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-03-19	Chudnovsky Yekaterina	Buy	1 032 702	Pre-Funded Common Stock Purchase Warrant
2024-02-01	Piekos Brian	Buy	43 225	Stock Option (right to buy)
2024-02-01	Connelly Robert	Buy	225 137	Stock Option (right to buy)
2024-02-01	Haqq Christopher	Buy	28 200	Stock Option (right to buy)
2024-02-01	Demuth Peter	Buy	29 800	Stock Option (right to buy)

INSIDER POWER
100.00
Last 6 transactions
Buy: 1 359 406 \| Sell: 0

Korrelasjon (AI algo v.1.1b): Undervalued: 0.02% $6.45 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Elicio Therapeutics, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Elicio Therapeutics, Inc. Økonomi

Annual	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-88.84

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-88.84

FY	2020
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.930

FY	2019
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.505

Financial Reports:

No articles found.

Elicio Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company\'s lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers. It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers; ELI-005, a vaccine candidate for the prevention of COVID-19; ELI-011 for the treatment of hematological cancers; and ELI-012, a mKRAS TCR T cell AMP-lifier designs to use in combination with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company is headquartered in Boston, Massachusetts.